PsyIndex Listing Alert: atai Life Sciences B.V.

CANNANNEW REPORT

atai Life Sciences B.V. began trading on the NASDAQ under the ticker symbol “ATAI” on June 18, 2021. atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The company was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. The company is headquartered in Berlin, with offices in New York and London. atai Life Sciences Announces Launch of Initial Public Offering  Ryan Allway  June 14th, 2021  Psychedelics atai Life Sciences B.V. (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the commencement of a proposed underwritten initial public offering of 14,286,000 of its common shares. All common shares to be sold in the proposed offering will be sold by atai. The underwriters of the offering will have a 30-day option to purchase up to an additional 2,142,900 common shares at the initial public offering price, less the underwriting discounts and commissions. The initial public offering price is expected to be between $13.00 and $15.00 per common share. atai has applied to list its common shares on the Nasdaq Global Market under the ticker symbol “ATAI.” Credit Suisse, Citigroup, Cowen, and Berenberg are acting as book-running managers for the proposed offering. Cantor, RBC Capital Markets and Canaccord Genuity are also acting as book-running managers for the proposed offering. The offering will be made only by means of a prospectus. A copy of the preliminary prospectus relating to this offering, when available, may be obtained by contacting Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, NC 27560, or…

Excerpt only …
READ MORE BELOW
Source : PsyIndex Listing Alert: atai Life Sciences B.V.

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.